Sam – Interview 20
Sam was diagnosed with CIN3 in 2009 at the age of 22. Over the course of two years, she had two LLETZ treatments and four or five biopsies. She found waiting between appointments very worrying and would have liked more information.
Sam was diagnosed with CIN3 in 2009 at the age of 22. Over the course of two years, she had two LLETZ treatments and four or five biopsies. She found waiting between appointments very worrying and would have liked more information.
More about me’
Sam had her first cervical screening test when she was 18 because she;d had some abnormal bleeding. The result was normal and she had her next test three years later at 21. This time the result was abnormal and she had a colposcopy appointment two weeks later.
When Sam attended the colposcopy clinic, she was treated there and then by LLETZ. Two weeks later, however, she received a letter telling her that she had unclear margins and CIN2. Sam was worried about her results and was given another appointment in three months.
At her next appointment, Sam was examined and had a biopsy taken. The results showed she had moderate cell changes, and she was asked to attend the clinic again in six months.
Six months later, Sam was given another biopsy and, again, results showed that she still had moderate changes. Her doctor advised her to stop smoking and, with the help of nicotine patches, both she and her partner quit smoking.
Sam’s next appointment was six months later where she was told that she had CIN3 and, again, would be treated by LLETZ. Sam said that, in all, 1½ years had passed by and, throughout this time, she had been unsure about what had actually been wrong and why she had to keep going back to the hospital. Sam felt that her doctor had not explained what she had, why she had to keep attending the clinic, and never answered her questions or listened to her concerns. She wondered if she would have received more information had she been older. Anxious, she made an appointment with her GP and was referred to another hospital where she would be seen by a different consultant.
Sam said that, in this appointment, her new consultant explained what CIN3 was and answered her questions. Throughout this time, now totalling two years, Sam said she worried that her condition could be getting worse.
Over about two years, Sam had two LLETZ treatments and, between these operations, four or five biopsies. She found the wait between appointments extremely worrying and would have liked more information. She said she felt much happier with the care and information she received from her second consultant, and advised other women to ask questions and voice their concerns. She also recommended the Jo’s Trust website, which she found extremely helpful and supportive (www. Jotrust. Co. Uk).